Absence of type 1 11β-hydroxysteroid dehydrogenase enzyme in koala liver

被引:4
|
作者
Kong, S [1 ]
McKinnon, RA [1 ]
Mojarrabi, B [1 ]
Stupans, I [1 ]
机构
[1] Univ S Australia, Sch Pharmaceut Mol & Biomed Sci, Pharmaceut Res Ctr, Adelaide, SA 5000, Australia
来源
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 2002年 / 131卷 / 01期
关键词
11 beta-hydroxysteroid dehydrogenase; hydroxysteroid oxidoreductase; cortisone; cortisol; deficiency; koala; marsupial; microsomal; liver; enzyme;
D O I
10.1016/S1532-0456(01)00278-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 11beta-hydroxysteroid dehydrogenases (11beta-HSDs) interconvert 11beta-hydroxysteroids such as cortisol into 11-oxosteroids such as cortisone. In most mammals, 11beta-HSD 1 is expressed predominantly in the liver and is active in both the oxidative (cortisol to cortisone) and dehydrogenase (cortisone to cortisol) directions, whilst 11beta-HSD 2 is expressed predominantly in the kidney and functions as a pure oxidative enzyme. We have investigated 11beta-HSD 1 activity in the Australian koala (Phascolarctos cinereus) and have found no activity (either reductive or oxidative) in hepatic microsomes. Immunoblot analysis of koala hepatic microsomes, using an 11beta-HSD 1 antibody raised against the mouse enzyme, failed to identify immunoreactive protein. Reverse transcriptase-polymerase chain reaction (RT-PCR) of koala liver mRNA and genomic PCR using primers designed against highly conserved regions of 11beta-HSD 1 nucleotide sequences were also negative. Furthermore, Southern and Northern blot analysis of koala genomic DNA and mRNA, respectively, confirmed that the koala lacks the 11beta-HSD 1 gene and gene transcript. These results support the fact that the lack of hepatic 11beta-HSD 1 activity in the koala is due to the absence of the 11beta-HSD 1 gene, and this absence is novel among mammalian species studied to date. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [21] 11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    T. M. Stulnig
    W. Waldhäusl
    Diabetologia, 2004, 47 : 1 - 11
  • [22] Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme
    Smith, RE
    Little, PJ
    Maguire, JA
    SteinOakley, AN
    Krozowski, ZS
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (6-7) : 549 - 551
  • [23] Clinical relevance of airway 11β-hydroxysteroid dehydrogenase type II enzyme in asthma
    Orsida, BE
    Krozowski, ZS
    Walters, EH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 1010 - 1014
  • [24] Monotoring 11β-hydroxysteroid dehydrogenase type 1 levels in mouse liver during caloric restriction
    Loerz, C.
    Maser, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S67 - S67
  • [25] Microglia Express Functional 11β-Hydroxysteroid Dehydrogenase Type 1
    Gottfried-Blackmore, Andres
    Sierra, Amanda
    Mcewen, Bruce S.
    Ge, Renshan
    Bulloch, Karen
    GLIA, 2010, 58 (10) : 1257 - 1266
  • [26] Piperidine amides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Flyren, Katarina
    Bergquist, Lars O.
    Castro, Victor M.
    Fotsch, Christopher
    Johansson, Lars
    Jean, David J. St., Jr.
    Sutin, Lori
    Williams, Meredith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3421 - 3425
  • [27] 11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
    Wake, DJ
    Walker, BR
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 215 (1-2) : 45 - 54
  • [28] 11β-hydroxysteroid dehydrogenase type 1 from human liver:: Dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase
    Maser, E
    Völker, B
    Friebertshäuser, J
    BIOCHEMISTRY, 2002, 41 (07) : 2459 - 2465
  • [29] Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1, and visceral obesity
    Paulmyer-Lacroix, O
    Boullu-Ciocca, S
    Oliver, C
    Dutour, A
    Grino, M
    M S-MEDECINE SCIENCES, 2003, 19 (04): : 473 - 476
  • [30] Perhydroquinolylbenzamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Coppola, GM
    Kukkola, PJ
    Stanton, JL
    Neubert, AD
    Marcopulos, N
    Bilci, NA
    Wang, H
    Tomaselli, HC
    Tan, J
    Aicher, TD
    Knorr, DC
    Jeng, AY
    Dardik, B
    Chatelain, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6696 - 6712